NCT05403437

Brief Summary

Pelvic girdle pain (PGP), which is a common musculoskeletal problem of pregnancy, and gestational diabetes mellitus (GDM), which is diagnosed at the end of the second trimester and at the beginning of the third trimester, occur in a parallel time period. The addition of hyperglycemia to the physiological changes in pregnancy stimulates a new series of cycles and contributes to inflammation, and it is predicted that the presence of GDM may trigger the pain intensity of PGP. Therefore, the aim of this study is to investigate the effect of GDM on PGP symptom severity (pain).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
155

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 3, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 18, 2025

Completed
Last Updated

March 26, 2025

Status Verified

March 1, 2025

Enrollment Period

2.3 years

First QC Date

April 15, 2022

Last Update Submit

March 21, 2025

Conditions

Keywords

pregnant womenpelvic girdle paingestational diabetes

Outcome Measures

Primary Outcomes (4)

  • Determining of painful areas

    Marking painful areas on the body chart

    Baseline (Current)

  • Evaluation of pain

    Pain will be evaluated with Visual Analog Scale (VAS). The VAS is scaled between 0-10 points (0: no pain, 10: most severe pain).

    Baseline (Current)

  • Application of PGP diagnostic tests

    Pelvic Girdle Pain diagnostic tests will be applied. No score defined for test.

    Baseline

  • Evaluation of PGP severity

    The severity of the pain that occurs in positive tests will be evaluated with VAS. The VAS is scaled between 0-10 points (0: no pain, 10: most severe pain).

    Baseline

Secondary Outcomes (3)

  • Pelvic Girdle Questionnaire

    Baseline

  • Evaluation of Body Weight

    Baseline

  • Evaluation of Body Mass Index (BMI)

    Baseline

Study Arms (3)

Group 1: Pregnant women with PGP and newly diagnosed with GDM

Pregnant women with PGP who were newly diagnosed with Gestational Diabetes Mellitus (GDM) according to routine control examinations and whose treatment for diabetes was not started

Other: Evaluation of painDiagnostic Test: Evaluation of pelvic girdle pain diagnostic testsOther: Evaluation of activity limitation

Group 2: Pregnant women with PGP and diagnosed with GDM

Pregnant women with PGP who were diagnosed with Gestational Diabetes Mellitus (GDM) according to routine control examinations and whose treatment has been already started for diabetes

Other: Evaluation of painDiagnostic Test: Evaluation of pelvic girdle pain diagnostic testsOther: Evaluation of activity limitation

Group 3: Pregnant women with PGP

Pregnant women with PGP who were not diagnosed with GDM according to routine control examinations

Other: Evaluation of painDiagnostic Test: Evaluation of pelvic girdle pain diagnostic tests

Interventions

Painful areas will be marked on the body chart. The presence and severity of pelvic girdle pain will be determined by the Visual Analog Scale (VAS).

Group 1: Pregnant women with PGP and newly diagnosed with GDMGroup 2: Pregnant women with PGP and diagnosed with GDMGroup 3: Pregnant women with PGP

Pelvic girdle pain diagnostic tests will be applied. The severity of the pain that occurs in positive tests will be evaluated with VAS.

Group 1: Pregnant women with PGP and newly diagnosed with GDMGroup 2: Pregnant women with PGP and diagnosed with GDMGroup 3: Pregnant women with PGP

The Pelvic Girdle Questionnaire will be filled.

Group 1: Pregnant women with PGP and newly diagnosed with GDMGroup 2: Pregnant women with PGP and diagnosed with GDM

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Pregnant women with PGP and GDM Pregnant women with PGP but without GDM

You may qualify if:

  • Pregnant women (with PGP) diagnosed with GDM in the 2nd and 3rd trimesters, whose treatment process (diet/insulin) for insulin regulation have been started.
  • Pregnant women (with PGP) diagnosed with GDM in the 2nd and 3rd trimesters, whose treatment process (diet/insulin) for insulin regulation have not been started
  • Pregnant women (with PGP) who were not diagnosed with GDM in the 2nd and 3rd trimesters

You may not qualify if:

  • Pre-pregnancy Diabetes Mellitus
  • Presence of an orthopedic or neurological problem that may cause musculoskeletal disorders and deviations from normal biomechanical alignment
  • Presence of connective tissue disease
  • Definition of chronic low back-pelvic region pain (lasting for more than 3 months and pain severity \>4 according to VAS) before pregnancy
  • History of spine, pelvis, or lower extremity surgery or fracture in the past 6 months
  • History of pelvic fracture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

İstanbul Medeniyet University

Istanbul, Turkey (Türkiye)

Location

Related Publications (5)

  • Aldabe D, Milosavljevic S, Bussey MD. Is pregnancy related pelvic girdle pain associated with altered kinematic, kinetic and motor control of the pelvis? A systematic review. Eur Spine J. 2012 Sep;21(9):1777-87. doi: 10.1007/s00586-012-2401-1. Epub 2012 Jun 21.

  • Palsson TS, Beales D, Slater H, O'Sullivan P, Graven-Nielsen T. Pregnancy is characterized by widespread deep-tissue hypersensitivity independent of lumbopelvic pain intensity, a facilitated response to manual orthopedic tests, and poorer self-reported health. J Pain. 2015 Mar;16(3):270-82. doi: 10.1016/j.jpain.2014.12.002. Epub 2014 Dec 23.

  • Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci. 2018 Oct 26;19(11):3342. doi: 10.3390/ijms19113342.

  • Eberhard-Gran M, Eskild A. Diabetes mellitus and pelvic girdle syndrome in pregnancy--is there an association? Acta Obstet Gynecol Scand. 2008;87(10):1015-9. doi: 10.1080/00016340802345944.

  • Wuytack F, O'Donovan M. Outcomes and outcomes measurements used in intervention studies of pelvic girdle pain and lumbopelvic pain: a systematic review. Chiropr Man Therap. 2019 Nov 5;27:62. doi: 10.1186/s12998-019-0279-2. eCollection 2019.

MeSH Terms

Conditions

Diabetes, GestationalPelvic Girdle Pain

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesMusculoskeletal PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPelvic Pain

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2022

First Posted

June 3, 2022

Study Start

June 1, 2022

Primary Completion

September 15, 2024

Study Completion

February 18, 2025

Last Updated

March 26, 2025

Record last verified: 2025-03

Locations